SUNNYVALE, Calif. - Sunday, May 5th 2013 [ME NewsWire]

(BUSINESS WIRE)-- DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research, today announced the introduction of the new CyTOF 2 Mass Cytometer and new MaxPar Panel Kits designed specifically for simultaneous high-parameter single cell analysis.

The DVS Sciences® CyTOF 2 system leverages the same mass cytometry technology that has been the foundation to the success and world-wide adoption of the CyTOF Mass Cytometer. The technology enables comprehensive functional and phenotypic characterization of complex systems at the single cell level in diverse disciplines including immunology, cancer research, stem cell biology and drug profiling. On a newly designed chassis, the CyTOF 2 system delivers enhanced performance and improved user experience, providing the most powerful cell analysis platform on the market. The CyTOF 2 platform uniquely has t ... Read more »

La société organisera une conférence téléphonique le lundi 6 mai

DUBLIN - Dimanche 5 Mai 2013 [ME NewsWire]

(BUSINESS WIRE)--La société Covidien (NYSE : COV), l'un des principaux fournisseurs de matériel médical à l'échelle mondiale, a annoncé aujourd'hui ses grandes orientations pour 2013 et rendu publics des états financiers historiques révisés pour tenir compte des activités qu'elle prévoit abandonner en raison de la cession de ses activités pharmaceutiques. Ces états financiers révisés couvrent les exercices 2010 à 2012, ainsi que le premier trimestre de l'exercice 2013. Ceux relatifs au deuxième trimestre seront rendus publics fin mai.

«Depuis l'annonce, en décembre 2011, de la cession de nos activités pharmaceutiques, nous avons fait des progrès considérables»

La société Covidien ... Read more »

First Trump Course in Asia to be ‘Among the Finest in the World’


Dubai, United Arab Emirates- - Sunday, May 5th 2013 [ME NewsWire]

DAMAC Properties, the largest private developer of luxury real estate in the Middle East, has announced plans to develop an 18-hole PGA Championship Golf Course, to be named Trump International Golf Club, Dubai.

The 7,205-yard, par 71 course will be located just ten minutes from Sheikh Zayed Road and sits at the heart of the 28 million square foot ‘Akoya by DAMAC’ master plan development - the launch of which was announced last week. Construction is already underway and the course will be ready for play next year.

Trump International Golf Club, Dubai will include a 30,000 square foot state-of-the-art club house and a luxurious Trump Spa & wellness centre, which will be managed to the highest standards by the Trump Organization.

"By collaborating with Donald Trump, we are bringing the most elite name in golf and in ... Read more »

Company will hold conference call on Monday, May 6

DUBLIN - Sunday, May 5th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced revised 2013 guidance and released historical financial statements adjusted for the upcoming expected discontinued operations, reflecting the planned spin-off of its Pharmaceuticals business. These adjusted financial statements cover fiscal years 2010 to 2012 and the first quarter of fiscal 2013. Adjusted financial statements for the second quarter of fiscal 2013 will be available by the end of May.

Covidien announced fiscal 2013 guidance to reflect the planned spin-off of its Pharmaceuticals business, a transaction that is expected to occur following the close of trading on June 28, 2013. The Company now estimates that net sales in fiscal 2013 will be up 4% to 5%, including foreign exchange at current rates. Sales are expected to be up 4% to 6% versus 2012 in the Me ... Read more »

SUNNYVALE dans l'État de Californie - Dimanche 5 Mai 2013 [ME NewsWire]

(BUSINESS WIRE)--DVS Sciences, Inc., un innovateur non coté de nouveaux analyseurs de cellules uniques à paramètres multiples et de réactifs pour la recherche biologique, a annoncé aujourd'hui l'introduction du nouveau cytomètre de masse CyTOF 2 et des nouveaux ensembles de panneaux MaxPar conçus spécifiquement pour l'analyse simultanée de cellules uniques à paramètres élevés.

Le système CyTOF 2 de DVS Sciences® tire profit de la même technologie de cytométrie de masse que celle qui a été à l'origine de la réussite et de l'adoption internationale du cytomètre de masse CyTOF. La technologie permet une caractérisation fonctionnelle et phénotypique complète de systèmes complexes au niveau de cellules uniques dans diverses disciplines, notamment l'immunologie, la recherche contre le cancer, la biologie de ... Read more »